Journal of Thoracic Oncology Oncology
Compound EGFR Mutations Are Predominantly P-Loop and Alpha-C Helix Compressing Mutations With Increased Responsiveness to Second- Versus Third-Generation Tyrosine Kinase Inhibitors
The publisher did not provide an abstract — full text is available via the link below.